285 related articles for article (PubMed ID: 19903563)
1. Chapter 17 - Engineering cationic liposome siRNA complexes for in vitro and in vivo delivery.
Podesta JE; Kostarelos K
Methods Enzymol; 2009; 464():343-54. PubMed ID: 19903563
[TBL] [Abstract][Full Text] [Related]
2. siRNA delivery by a transferrin-associated lipid-based vector: a non-viral strategy to mediate gene silencing.
Cardoso AL; Simões S; de Almeida LP; Pelisek J; Culmsee C; Wagner E; Pedroso de Lima MC
J Gene Med; 2007 Mar; 9(3):170-83. PubMed ID: 17351968
[TBL] [Abstract][Full Text] [Related]
3. Enhanced cellular uptake and gene silencing activity of siRNA using temperature-responsive polymer-modified liposome.
Wang J; Ayano E; Maitani Y; Kanazawa H
Int J Pharm; 2017 May; 523(1):217-228. PubMed ID: 28330734
[TBL] [Abstract][Full Text] [Related]
4. Elucidating the encapsulation of short interfering RNA in PEGylated cationic liposomes.
Buyens K; Demeester J; De Smedt SS; Sanders NN
Langmuir; 2009 May; 25(9):4886-91. PubMed ID: 19341292
[TBL] [Abstract][Full Text] [Related]
5. Engineering of small interfering RNA-loaded lipidoid-poly(DL-lactic-co-glycolic acid) hybrid nanoparticles for highly efficient and safe gene silencing: A quality by design-based approach.
Thanki K; Zeng X; Justesen S; Tejlmann S; Falkenberg E; Van Driessche E; Mørck Nielsen H; Franzyk H; Foged C
Eur J Pharm Biopharm; 2017 Nov; 120():22-33. PubMed ID: 28756280
[TBL] [Abstract][Full Text] [Related]
6. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
7. Efficient siRNA delivery using novel siRNA-loaded Bubble liposomes and ultrasound.
Endo-Takahashi Y; Negishi Y; Kato Y; Suzuki R; Maruyama K; Aramaki Y
Int J Pharm; 2012 Jan; 422(1-2):504-9. PubMed ID: 22119963
[TBL] [Abstract][Full Text] [Related]
8. Lipoplexes from Non-viral Cationic Vectors: DOTAP-DOPE Liposomes and Gemini Micelles.
Falsini S; Ristori S
Methods Mol Biol; 2016; 1445():33-43. PubMed ID: 27436311
[TBL] [Abstract][Full Text] [Related]
9. Complexation of siRNA and pDNA with cationic liposomes: the important aspects in lipoplex preparation.
Barichello JM; Ishida T; Kiwada H
Methods Mol Biol; 2010; 605():461-72. PubMed ID: 20072901
[TBL] [Abstract][Full Text] [Related]
10. Structure and gene silencing activities of monovalent and pentavalent cationic lipid vectors complexed with siRNA.
Bouxsein NF; McAllister CS; Ewert KK; Samuel CE; Safinya CR
Biochemistry; 2007 Apr; 46(16):4785-92. PubMed ID: 17391006
[TBL] [Abstract][Full Text] [Related]
11. Delivery of Therapeutic siRNA to the CNS Using Cationic and Anionic Liposomes.
Bender HR; Kane S; Zabel MD
J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501362
[TBL] [Abstract][Full Text] [Related]
12. Neutral PEGylated liposomal formulation for efficient folate-mediated delivery of MCL1 siRNA to activated macrophages.
Nogueira E; Freitas J; Loureiro A; Nogueira P; Gomes AC; Preto A; Carmo AM; Moreira A; Cavaco-Paulo A
Colloids Surf B Biointerfaces; 2017 Jul; 155():459-465. PubMed ID: 28472749
[TBL] [Abstract][Full Text] [Related]
13. Asymmetric liposome particles with highly efficient encapsulation of siRNA and without nonspecific cell penetration suitable for target-specific delivery.
Mokhtarieh AA; Cheong S; Kim S; Chung BH; Lee MK
Biochim Biophys Acta; 2012 Jul; 1818(7):1633-41. PubMed ID: 22465072
[TBL] [Abstract][Full Text] [Related]
14. Preparation of PEGylated cationic nanoliposome-siRNA complexes for cancer therapy.
Haghiralsadat F; Amoabediny G; Naderinezhad S; Forouzanfar T; Helder MN; Zandieh-Doulabi B
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):684-692. PubMed ID: 29475393
[TBL] [Abstract][Full Text] [Related]
15. Hyaluronic acid-modified DOTAP/DOPE liposomes for the targeted delivery of anti-telomerase siRNA to CD44-expressing lung cancer cells.
Taetz S; Bochot A; Surace C; Arpicco S; Renoir JM; Schaefer UF; Marsaud V; Kerdine-Roemer S; Lehr CM; Fattal E
Oligonucleotides; 2009 Jun; 19(2):103-16. PubMed ID: 19374532
[TBL] [Abstract][Full Text] [Related]
16. Ultradeformable cationic liposomes for delivery of small interfering RNA (siRNA) into human primary melanocytes.
Geusens B; Lambert J; De Smedt SC; Buyens K; Sanders NN; Van Gele M
J Control Release; 2009 Feb; 133(3):214-20. PubMed ID: 18973779
[TBL] [Abstract][Full Text] [Related]
17. One-step scalable preparation method for non-cationic liposomes with high siRNA content.
Somiya M; Yamaguchi K; Liu Q; Niimi T; Maturana AD; Iijima M; Yoshimoto N; Kuroda S
Int J Pharm; 2015 Jul; 490(1-2):316-23. PubMed ID: 26027493
[TBL] [Abstract][Full Text] [Related]
18. Anti-angiogenic therapy via cationic liposome-mediated systemic siRNA delivery.
Tagami T; Suzuki T; Matsunaga M; Nakamura K; Moriyoshi N; Ishida T; Kiwada H
Int J Pharm; 2012 Jan; 422(1-2):280-9. PubMed ID: 22101286
[TBL] [Abstract][Full Text] [Related]
19. Liposomal siRNA delivery.
Hughes J; Yadava P; Mesaros R
Methods Mol Biol; 2010; 605():445-59. PubMed ID: 20072900
[TBL] [Abstract][Full Text] [Related]
20. Lipid-based nanoparticles for siRNA delivery in cancer therapy: paradigms and challenges.
Gomes-da-Silva LC; Fonseca NA; Moura V; Pedroso de Lima MC; Simões S; Moreira JN
Acc Chem Res; 2012 Jul; 45(7):1163-71. PubMed ID: 22568781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]